These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16143170)

  • 21. Defining mild cognitive impairment in Parkinson's disease.
    Caviness JN; Driver-Dunckley E; Connor DJ; Sabbagh MN; Hentz JG; Noble B; Evidente VG; Shill HA; Adler CH
    Mov Disord; 2007 Jul; 22(9):1272-7. PubMed ID: 17415797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis.
    Shi J; Zhao CB; Vollmer TL; Tyry TM; Kuniyoshi SM
    Neurology; 2008 Jan; 70(3):185-90. PubMed ID: 17460153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis.
    Dineen RA; Vilisaar J; Hlinka J; Bradshaw CM; Morgan PS; Constantinescu CS; Auer DP
    Brain; 2009 Jan; 132(Pt 1):239-49. PubMed ID: 18953055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current management of the cognitive dysfunction in Parkinson's disease: how far have we come?
    Vale S
    Exp Biol Med (Maywood); 2008 Aug; 233(8):941-51. PubMed ID: 18535172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The recognition of facial emotion expressions in Parkinson's disease.
    Assogna F; Pontieri FE; Caltagirone C; Spalletta G
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):835-48. PubMed ID: 18707851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wisconsin Card Sorting Test in Parkinson's disease: diffusion tensor imaging.
    Matsui H; Nishinaka K; Oda M; Niikawa H; Komatsu K; Kubori T; Udaka F
    Acta Neurol Scand; 2007 Aug; 116(2):108-12. PubMed ID: 17661796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia.
    Janvin CC; Larsen JP; Aarsland D; Hugdahl K
    Mov Disord; 2006 Sep; 21(9):1343-9. PubMed ID: 16721732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's disease.
    Caviness JN; Hentz JG; Evidente VG; Driver-Dunckley E; Samanta J; Mahant P; Connor DJ; Sabbagh MN; Shill HA; Adler CH
    Parkinsonism Relat Disord; 2007 Aug; 13(6):348-54. PubMed ID: 17347022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variation in the myeloperoxidase gene and cognitive impairment in multiple sclerosis.
    Manna I; Valentino P; La Russa A; Condino F; Nisticò R; Liguori M; Clodomiro A; Andreoli V; Pirritano D; Cittadella R; Quattrone A
    J Negat Results Biomed; 2006 Feb; 5():3. PubMed ID: 16504169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonmotor symptoms of Parkinson's disease.
    Zesiewicz TA; Sullivan KL; Hauser RA
    Expert Rev Neurother; 2006 Dec; 6(12):1811-22. PubMed ID: 17181428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropsychological assessment: experimental and clinical research.
    Falautano M
    Neurol Sci; 2010 Nov; 31(Suppl 2):S223-6. PubMed ID: 20640469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive dysfunction in multiple sclerosis: the effect of pharmacological interventions.
    Lyros E; Messinis L; Papageorgiou SG; Papathanasopoulos P
    Int Rev Psychiatry; 2010; 22(1):35-42. PubMed ID: 20222786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pain in Parkinson's disease.
    Ford B
    Mov Disord; 2010; 25 Suppl 1():S98-103. PubMed ID: 20187254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pain in Parkinson's disease.
    Ford B
    Clin Neurosci; 1998; 5(2):63-72. PubMed ID: 10785830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations.
    Rogers JM; Panegyres PK
    J Clin Neurosci; 2007 Oct; 14(10):919-27. PubMed ID: 17659875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between event-related potentials and frontal-subcortical dysfunction in Parkinson's disease.
    Chen KJ; Lin RT; Liu CK; Tai CT; Lai CL
    Parkinsonism Relat Disord; 2006 Oct; 12(7):453-8. PubMed ID: 16793318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument.
    Kalbe E; Calabrese P; Kohn N; Hilker R; Riedel O; Wittchen HU; Dodel R; Otto J; Ebersbach G; Kessler J
    Parkinsonism Relat Disord; 2008; 14(2):93-101. PubMed ID: 17707678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?
    Kish SJ
    Adv Neurol; 2003; 91():39-49. PubMed ID: 12442662
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiorespiratory fitness: A predictor of cortical plasticity in multiple sclerosis.
    Prakash RS; Snook EM; Erickson KI; Colcombe SJ; Voss MW; Motl RW; Kramer AF
    Neuroimage; 2007 Feb; 34(3):1238-44. PubMed ID: 17134916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.